Jarow Jonathan P, Baxley John H
US Food and Drug Administration, Silver Spring, MD.
US Food and Drug Administration, Silver Spring, MD.
Urol Oncol. 2015 Mar;33(3):128-32. doi: 10.1016/j.urolonc.2014.10.004. Epub 2014 Nov 6.
Medical devices are regulated by the US Food and Drug Administration (FDA) within the Center for Devices and Radiological Health. Center for Devices and Radiological Health is responsible for protecting and promoting the public health by ensuring the safety, effectiveness, and quality of medical devices, ensuring the safety of radiation-emitting products, fostering innovation, and providing the public with accurate, science-based information about the products we oversee, throughout the total product life cycle. The FDA was granted the authority to regulate the manufacturing and marketing of medical devices in 1976. It does not regulate the practice of medicine. Devices are classified based on complexity and level of risk, and "pre-1976" devices were allowed to remain on the market after being classified without FDA review. Post-1976 devices of lower complexity and risk that are substantially equivalent to a marketed "predicate" device may be cleared through the 510(k) premarket notification process. Clinical data are typically not needed for 510(k) clearance. In contrast, higher-risk devices typically require premarket approval. Premarket approval applications must contain data demonstrating reasonable assurance of safety and efficacy, and this information typically includes clinical data. For novel devices that are not high risk, the de novo process allows FDA to simultaneously review and classify new devices. Devices that are not legally marketed are permitted to be used for clinical investigation purposes in the United States under the Investigational Device Exemptions regulation.
美国食品药品监督管理局(FDA)下属的器械与放射健康中心负责监管医疗器械。器械与放射健康中心负责通过确保医疗器械的安全性、有效性和质量,确保辐射发射产品的安全性,促进创新,并在整个产品生命周期内向公众提供有关我们所监管产品的准确、基于科学的信息,来保护和促进公众健康。FDA于1976年被授予监管医疗器械制造和销售的权力。它不监管医疗实践。器械根据复杂性和风险水平进行分类,“1976年前”的器械在分类后无需FDA审查即可继续留在市场上。1976年后复杂性和风险较低且与已上市的“同类参照”器械实质等同的器械,可通过510(k)上市前通知程序获得批准。510(k)批准通常不需要临床数据。相比之下,高风险器械通常需要上市前批准。上市前批准申请必须包含证明安全性和有效性合理保证的数据,这些信息通常包括临床数据。对于非高风险的新型器械,“从头开始”程序允许FDA同时对新器械进行审查和分类。根据研究性器械豁免规定,在美国,未合法上市的器械可用于临床研究目的。